<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------
POST-EFFECTIVE
AMENDMENT NO. 1
TO
FORM 10-SB
GENERAL FORM FOR REGISTRATION OF SECURITIES
OF SMALL BUSINESS ISSUERS UNDER SECTION 12(b) OR 12(g)
OF THE SECURITIES EXCHANGE ACT OF 1934
THE CHROMALINE CORPORATION
-----------------------------------------------------------------
(Exact name of Small Business Issuer as specified in its charter)
Minnesota 41-0730027
- ---------------------------------------- -------------------------------
(State of incorporation or organization) (I.R.S. Employer Identification
No.)
4832 Grand Avenue
Duluth, Minnesota 55807
- ---------------------------------------- -------------------------------
(Address of principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
None
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, $.10 par value
----------------------------
(Title of Class)
<PAGE>
PART I
ITEM 1. DESCRIPTION OF BUSINESS
GENERAL
The Chromaline Corporation ("Chromaline" or the "Company") was
incorporated in Minnesota as Chroma-Glo, Inc. in 1952 and changed its name to
The Chromaline Corporation in 1982. The Company develops, manufactures and sells
light sensitive liquid coatings ("emulsions") and light sensitive films for
commercial and industrial applications in the United States and abroad. The
Company also markets ancillary chemicals and equipment to provide a full line of
products and services to its customers. The Company's products serve the screen
printing and decorative sand blasting markets. The screen printing products
represent the Company's largest product line. These products are used by screen
printers to create stencil images. These images produce basic designs for fabric
decoration and product identification, as well as complex designs for compact
discs and electronic circuits. The sand blasting products are used by many
consumers to create architectural glass, art pieces and awards. Some of the
Company's customers use both the screen printing and the sand blasting products.
Over the past three years, Chromaline has completed building additions
which add additional manufacturing and warehouse space and has installed
equipment which doubles the Company's coated film production capacity. During
this period, the Company has grown by developing new products, including:
- Chroma/Tech SR - a new solvent resistant pure photopolymer
emulsion.
- Magna/Cure UDC1, 2 and 3 - universal dual care emulsions.
- Chroma/Tech PL-2 - pure photopolymer emulsion for use with
plastisol inks.
- Magna/Cure UDC-HV - universal dual cure with high viscosity.
- MAX-R film - for maximum resistance to water or solvent base
inks.
- MAX-R emulsion - for maximum resistance to water or solvent
base inks.
- PHAT film - for screen printing images that require 100
microns to 700 microns of new high density plastisol inks.
Prior to 1996, the Company sold products to several European
distributors and dealers and established a branch sales office in Europe. In
1996, the Company converted its European branch office to a marketing and sales
joint venture with Europeans involved in the screen printing industry, including
several Chromaline distributors and dealers. The joint venture entity,
Chromaline Europe, S.A., a French corporation located in Saverne, France
("Chromaline Europe"), began operations in January 1997. The Company is a 19.5%
owner of the joint venture.
PRODUCTS
Chromaline's core technology is photochemical imaging systems. This
technology is similar to photographic film technology except that the Company
uses organic polymers or natural protein rather than silver to make the product
photo-reactive ("light sensitive"). The products Chromaline targets at the
screen printing industry are light sensitive films and light sensitive liquid
coatings ("emulsions") used by customers to create an image on a printing
screen; the equivalent of a printing plate in other types of printing processes.
In the sand blasting market, the Company's products are also films and
emulsions. These products are used to create a stencil by decorators of glass
and other hard surfaces including crystal, marble, metals, wood, stone and
plastics. The stencil is applied directly to the article to be decorated by the
sand blasting process through a self-adhesive feature or with a separate
adhesive. The open areas of the stencil permit the sand blast grit to erode the
surface while the closed areas of the stencil repel the sand blast grit,
protecting areas of the surface being decorated.
All of Chromaline's light sensitive products are sensitive to
ultraviolet radiation. The Company uses different chemicals to create
sensitivity to light including a molecule which it developed internally and
patented.
-2-
<PAGE>
DISTRIBUTION
The Company currently has approximately 140 domestic and international
distributors. Chromaline sells its products through non-exclusive distributors
in competitive markets, such as the United States, Canada and Mexico. The
Company has exclusive distribution arrangements in markets without access to
alternative products, such as South and Central America, Australia, South
Africa, Canada, India and other Asian countries. The Company also sells its
products through direct sales to certain end users who do not require the
services of a distributor or dealer to service their account. In addition,
Chromaline markets and sells its products through magazine advertising, trade
shows and the internet.
Chromaline is engaged in international sales through three channels.
Chromaline Europe imports the Company's products and distributes them to dealers
throughout Western and Eastern Europe and North Africa. The Company is also
currently developing its business in India through an exclusive distributor in
that country. It is the Company's intent that an entity to be formed by the
Company and the Indian distributor will eventually become a licensed
manufacturer of certain low cost products which have been developed by
Chromaline expressly for distant markets where shipping costs and low market
prices would otherwise preclude the Company's participation. The Company markets
products to foreign areas not served by the European or Indian facilities from
its corporate headquarters in Duluth, Minnesota.
Chromaline has a diverse customer base both domestically and abroad and
does not depend on one or a few customers for a material portion of its
revenues.
QUALITY CONTROL IN MANUFACTURING
In March 1994, Chromaline became the first firm in northern Minnesota
to receive ISO 9001 certification. ISO 9000 is a series of worldwide standards
issued by the International Organization for Standardization that provide a
framework for quality assurance. ISO 9001 is the most comprehensive standard of
the ISO 9000 series. The Company was recertified in 1997 and 1999. The
recertification process will occur every three years hereafter. Chromaline's
quality function goal is to train all employees properly in both their work and
in the importance of their work. Responsibility for efficient and correct work
has meant that authority for proposing changes has been given to all employees.
Internal records of quality related graphs and tables are reviewed regularly and
discussions are held among management and employees regarding how improvements
might be realized. The Company has rigorous materials selection procedures and
also uses environmental testing and screen print equipment tailored to fit
customers' needs.
RESEARCH AND DEVELOPMENT/INTELLECTUAL PROPERTY
Chromaline spent 7.3% of sales ($680,000) on research and development
in 1998 and 6.8% ($604,000) in 1997. In its research program, Chromaline has
developed unique light sensitive molecules which have received two U.S. patents.
These patents expire in 2011 and 2014, respectively. The Company also has four
United States patent applications pending. There can be no assurance that any
patent granted to the Company will provide adequate protection to the Company's
intellectual property. Within Chromaline, steps are taken to protect the
Company's trade secrets, including physical security, confidentiality and
non-competition agreements with employees and confidentiality agreements with
vendors. In its product development program, Chromaline is fully equipped to
simulate customer uses of its products. The Company's facilities include a
walk-in environmental chamber which simulates customer uses and storage
conditions of Chromaline products for different climatic zones.
In addition to its patents, the Company has various trademarks
including the "Chromaline" and "PhotoBrasive" trademarks.
RAW MATERIALS
The primary raw materials used by Chromaline in its production are
photopolymers, polyester films, polyvinylacetates, polyvinylalcohols and water.
The Company purchases raw materials from a variety of domestic
-3-
<PAGE>
and foreign sources with no one supplier being material to the Company. The
purchasing staff at the Company's headquarters leads in the identification of
both domestic and foreign sources for raw materials and negotiates price and
terms for all domestic and foreign markets. Chromaline's involvement in
foreign markets has given it the opportunity to become a global buyer of raw
materials at lower overall cost than it had previously enjoyed. The Company
has a number of suppliers and no one supplier is essential to the Company's
operations. To date there have been no significant shortages of raw materials
and alternative sources for nearly all raw materials are available. The
Company believes it has good supplier relations.
COMPETITION
The Company competes in its markets based on product development
capability, quality, reliability, availability, technical support and price. The
screen printing market is much larger than the decorative sand blasting market,
however, the sand blasting market is currently experiencing faster growth.
Chromaline has two primary competitors in its screen printing film business.
Both are larger than Chromaline and possess greater resources than the Company
in many areas. One is a privately owned U.S. firm and the other is owned by a
large British conglomerate. The Company has numerous competitors in the market
for screen print emulsions many of whom are larger than Chromaline and possess
greater resources. The market for the Company's sand blasting products has
relatively few competitors, however, those in this market compete aggressively
on price and in other areas. Chromaline considers itself to be a significant
factor in this market.
GOVERNMENT REGULATION
The Company is subject to a variety of federal, state and local
industrial laws and regulations, including those relating to the discharge of
material into the environment and protection of the environment. The
governmental authorities primarily responsible for regulating the Company's
environmental compliance are the Environmental Protection Agency, the Minnesota
Pollution Control Agency and the Western Lake Superior Sanitary District.
Failure to comply with the laws promulgated by these authorities may result in
monetary sanctions, liability for environmental clean-up and other equitable
remedies. To maintain compliance, the Company may make occasional changes in its
waste generation and disposal procedures.
These laws and regulations have not had a material effect upon the
capital expenditures or competitive position of the Company. The Company
believes that it complies in all material respects with the various federal,
state and local regulations that apply to its current operations. Failure to
comply with these regulations could have a negative impact on the Company's
operations and capital expenditures and such negative impact could be
significant.
EMPLOYEES
As of May 10, 1999, the Company had 73 employees, including 71
full-time employees, all of whom are located at the Company's headquarters in
Duluth, Minnesota with the exception of four outside technical sales
representatives in various locations around the United States. None of the
Company's employees are subject to a collective bargaining agreement and the
Company believes that its employee relations are good.
-4-
<PAGE>
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
The following management discussion and analysis focuses on those
factors that had a material effect on the Company's financial results of
operations and financial condition during 1998 and 1997 and should be read in
connection with the Company's audited financial statements and notes thereto for
the years ending December 31, 1998 and 1997.
FACTORS THAT MAY AFFECT FUTURE RESULTS
Certain statements made in this Registration Statement on Form 10-SB,
which are summarized below, are forward-looking statements that involve risks
and uncertainties, and actual results may be materially different. Factors that
could cause actual results to differ include, but are not limited to, those
identified as follows:
- THE COMPANY'S BELIEF THAT FOREIGN ECONOMIES ARE
STABILIZING--This belief may be impacted by economic,
political and social conditions in foreign markets and changes
in regulatory and competitive conditions.
- THE BELIEF THAT THE COMPANY'S CURRENT FINANCIAL RESOURCES,
CASH GENERATED FROM OPERATIONS AND THE COMPANY'S CAPACITY FOR
DEBT AND/OR EQUITY FINANCING WILL BE SUFFICIENT TO FUND
CURRENT AND ANTICIPATED BUSINESS OPERATIONS--Changes in
anticipated operating results, credit availability and equity
market conditions may further enhance or inhibit the Company's
ability to maintain or raise appropriate levels of cash.
- THE COMPANY'S PLANS TO EXPAND ITS RESEARCH AND DEVELOPMENT
EFFORTS AND THE EXPECTED FOCUS AND RESULTS OF SUCH
EFFORTS--These plans and expectations may be impacted by
general market conditions, unanticipated changes in expenses
or sales, delays in the development of new products,
technological advances or other changes in competitive
conditions.
- THE COMPANY'S EFFORTS TO GROW ITS INTERNATIONAL
BUSINESS--These efforts may be impacted by economic, political
and social conditions in current and anticipated foreign
markets, regulatory conditions in such markets, unanticipated
changes in expenses or sales, changes in competitive
conditions or other barriers to entry or expansion.
- THE COMPANY'S BELIEF THAT EVALUATIONS AND MODIFICATIONS OF
YEAR 2000 COMPLIANCE ISSUES, INCLUDING YEAR 2000 COMPLIANCE OF
THIRD-PARTY SUPPLIERS, WILL NOT HAVE A MATERIAL ADVERSE EFFECT
ON THE COMPANY'S OPERATIONS OR FINANCIAL POSITION--This belief
may be impacted by presently unanticipated delays in
assessment or remediation, unanticipated increases in costs or
non-compliance by third parties.
- THE COMPANY'S EXPECTATIONS OF THE TIME AND COSTS ASSOCIATED
WITH ITS YEAR 2000 PROJECT--These expectations may be impacted
by presently unanticipated delays in assessment, unanticipated
increases in costs or non-compliance by third parties.
- THE EXPECTATION THAT THE COMPANY WILL HAVE A MANUFACTURER OF
CERTAIN LOW COST PRODUCTS IN INDIA--This expectation may be
impacted by economic, political and social conditions or
regulatory changes in India, unanticipated delays or expenses,
acceptance of the Company's products or changes in competitive
conditions.
-5-
<PAGE>
RESULTS OF OPERATIONS
QUARTER ENDED MARCH 31, 1999 COMPARED TO QUARTER ENDED MARCH 31, 1998
SALES. The Company's sales in the first quarter of 1999 decreased to
$2.2 million, a 4.5% decrease from $2.3 million during the same period in 1998.
The decline is attributable to weak markets in Asia and Europe. The Company
believes that this trend is improving as foreign economies show signs of
stabilizing.
COST OF GOODS SOLD. The cost of goods sold during the first quarter of
1999 was $1.1 million, or 47.5% of sales, compared to $1.1 million, or 46.5% of
sales, during the same period in 1998.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES. Selling, general and
administrative expenses increased to $789,000, or 35.3% of sales, in the first
quarter of 1999 from $713,000, or 30.5% of sales, for the same period in 1998.
The increase resulted from increased expenditures on the promotion of new
products and the costs associated with the filing of a registration statement
under the Securities Exchange Act of 1934, as amended, covering the Company's
Common Stock.
RESEARCH AND DEVELOPMENT EXPENSES. Research and development expenses
during the first quarter of 1999 increased to $162,000, or 7.2% of sales, from
$157,000, or 6.7% of sales, during the first quarter of 1998. The increase
resulted from expenditures to maintain and increase the technological
development of the Company's products.
INCOME TAXES. Income taxes decreased to $84,000 in the first quarter of
1999 from $148,000 in the first quarter of 1998. The decrease was primarily due
to a reduction in the Company's pretax income in 1999.
NET INCOME. Net income decreased in the first quarter of 1999 to
$143,000 from $242,000 during the same period in 1998. The decrease was
primarily due to reduced sales and increased expenses for the development of new
products.
YEAR ENDED DECEMBER 31, 1998 COMPARED TO YEAR ENDED DECEMBER 31, 1997
SALES. The Company's sales increased by 4.4% to $9.3 million in 1998
from $8.9 million in 1997. This increase was primarily due to a 15.2% increase
in international sales.
COST OF GOODS SOLD. The cost of goods sold was $4.2 million, or 45.1%
of sales, in 1998 and $4.2 million, or 46.9% of sales, in 1997, gross margins
improved as overhead and labor costs increased slightly and the cost of raw
materials remained relatively flat.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES. Selling, general and
administrative expenses increased to $3.1 million, or 33.1% of sales, in 1998
from $2.7 million, or 30.0% of sales, in 1997. This increase was primarily due
to approximately $240,000 of one-time costs associated with the retirement and
replacement of two senior officers and increased sales and marketing expenses
associated with the launch of new products.
RESEARCH AND DEVELOPMENT EXPENSES. Research and development expenses
increased to $680,000, or 7.3% of sales, in 1998 from $604,000, or 6.8% of
sales, in 1997. This increase was primarily due to expenses incurred to complete
development of PHAT film, a film which utilizes new high density inks to create
suede-like and 3-D images, and the MAX-R emulsion, an emulsion which has maximum
resistance to breakdown thus improving screen printers' production efficiency.
PHAT film and the MAX-R emulsion were launched at the Screenprinting and
Graphics Imaging Association trade show in October 1998.
PATENT LITIGATION EXPENSES. Recognized expenses related to the
Company's patent litigation decreased to zero in 1998 from $445,000 in 1997.
This decrease was due to the fact that all patent litigation costs incurred in
1998 were covered by the $250,000 accrual which was included in the $445,000
patent litigation expense incurred in 1997.
-6-
<PAGE>
INTEREST INCOME. Interest income increased to $29,000 in 1998 from
$10,000 in 1997. This increase was primarily due to the Company's purchase of
certain interest-bearing securities in 1998.
INCOME TAXES. While the Company's effective tax rate decreased to 35.8%
in 1998 from 38.6% in 1997, federal and state income tax expense increased to
$492,000 in 1998 from $371,000 in 1997. This increase in expense was due to the
increase in the Company's pretax income for 1998.
NET INCOME. Net income increased to $881,000 in 1998 from $638,375 in
1997. Net income in 1997 was negatively impacted by a total of $445,000 in
patent litigation costs during the year, while 1998 saw $240,000 of one-time
costs related to the retirement and replacement of two senior officers. Without
these one-time costs, net income in 1998 increased by 12.6% over 1997. This
increase was due to a 4.4% increase in sales and continuing efforts to improve
operating efficiencies and reduce costs.
LIQUIDITY AND CAPITAL RESOURCES
Chromaline has financed its operations principally with funds generated
from operations. These funds have been sufficient to cover the Company's normal
operating expenditures and annual capital spending requirements, as well as
research and development expenditures.
Cash and cash equivalents were $479,000, $275,000 and $732,000 at March
31, 1999, December 31, 1998 and December 31, 1997, respectively. The Company
generated $225,000 in cash from operating activities in the quarter ending March
31, 1999 and $507,000 and $1,117,000 in cash from operating activities in 1998
and 1997, respectively. Cash generated by operating activities is primarily
provided by net income as adjusted for non-cash depreciation. In 1998,
inventories increased by $289,000 due to additional finished goods in inventory
to support new product launches. During 1998, the Company also expended $445,000
to reduce accruals for sales and marketing costs, legal costs and income taxes.
In 1997, an increase in non-cash accrued expenses of $250,000 related to legal
costs was offset in part by a net reduction of $147,000 in accounts payable.
The Company used $23,000 in cash for investing activities in the
quarter ending March 31, 1999. The Company used $1,015,000 and $421,000 in cash
for investing activities in 1998 and 1997, respectively. In each period, net
cash used for investing activities relates primarily to the purchases of
property and equipment. In addition, during 1998 the Company purchased municipal
revenue bonds with maturities of three years or less for $909,000 and generated
$401,000 in cash from the sale of such marketable securities. The Company also
purchased a patent for $109,000 in 1998.
The Company generated $2,000 in cash from financing activities for the
quarter ending March 31, 1999 as a result of stock options exercised. The
Company generated $50,000 in cash from financing activities in 1998. In 1998,
financing activities included net proceeds of $72,000 from the exercise of stock
options, offset in part by a $22,000 payment on an outstanding note payable. The
Company used $34,000 in cash from financing activities in 1997. In 1997,
financing activities included a $38,000 payment on an outstanding note payable,
offset in part by $4,000 in exercised stock options.
A bank line of credit exists providing for borrowings of up to
$1,250,000. Outstanding debt under this line of credit is collateralized by
accounts receivable and bears interest at 2.25 percentage points over the 30-day
LIBOR rate. The Company has not utilized this line of credit to a material
extent and there was no debt outstanding under this line as of March 31, 1999. A
possible second source of funding is Tax Increment Financing ("TIF"). The
Company resides in one of several TIF districts in Duluth, Minnesota. TIF uses
the increase in tax revenues that results from development to fund the costs of
such development. This funding may be used to help facilitate improvements or
additions to the Company's property and buildings.
The Company believes that current financial resources, cash generated
from operations and the Company's capacity for debt and/or equity financing will
be sufficient to fund current and anticipated business operations.
-7-
<PAGE>
Future activities undertaken to expand the Company's business may include
acquisitions, building expansion and additions, equipment additions, new
product development and marketing opportunities.
CAPITAL EXPENDITURES
In 1998, the Company purchased over an acre of additional land
immediately adjacent to its manufacturing facility in Duluth at a cost of
$64,000. In addition, the Company acquired the E-Z Mask patent at a cost of
$109,000 to aid in the development of its decorative sand blasting business.
Additional plant equipment, research and development instrumentation, and
computers were purchased during 1998 and the quarter ended March 31, 1999 to
improve product quality and operating efficiency.
Commitments for capital expenditures include building maintenance,
research and development of equipment to modernize the capabilities and
processes of Chromaline's laboratory and research and development of equipment
to improve measurement and quality control processes. These commitments will be
funded by cash generated from operating activities.
INTERNATIONAL ACTIVITY
The Company markets its products to over 50 countries in North America,
Europe, Latin America, Asia and other parts of the world. Foreign sales were
approximately 32% and 29% of total sales in 1998 and 1997. Recent weakening of
certain foreign currencies has not significantly impacted the Company's
operations, because the Company's foreign sales are not concentrated in any one
region of the world. The Company believes its vulnerability to uncertainties due
to foreign currency fluctuations and general economic conditions in foreign
countries is not significant.
Substantially all of the Company's foreign transactions are negotiated,
invoiced and paid in U.S. dollars. Chromaline has not implemented a hedging
strategy to reduce the risk of foreign currency translation exposures, which
management does not believe to be significant based on the scope and geographic
diversity of the Company's foreign operations as of May 10, 1999.
Effective January 1, 1999, eleven states of the European Union began
the conversion to a common currency, called the "euro." This action will most
likely cause a portion of Chromaline's European transactions to be negotiated,
invoiced and paid in "euros." The conversion will most likely add currency
exchange costs and risks. Although such costs and risks are not quantifiable at
this time, they are not expected to be significant.
YEAR 2000 ISSUE
The year 2000 issue is the result of certain computer systems that
recognize the year using the last two digits. Any system utilizing
time-sensitive programming may recognize the date using "00" as the year 1900
rather than the year 2000. This could result in systems failure that may disrupt
normal business operations.
The Company began a comprehensive project in 1998 to test and prepare
its internal systems for the year 2000. The Company expects this project to be
completed in the third quarter of 1999. The project is on track to be completed
as planned. The project will replace all non-compliant software and hardware
with systems that are year 2000 compliant. This includes a review of both
information technology and non-information technology systems. A survey of major
suppliers is also being conducted as part of the project to assess the readiness
of the Company's business associates. If the necessary conversions are not
completed on a timely basis, the year 2000 could have a material adverse effect
on Chromaline's operations. Overall, management believes the year 2000 will not
have a significant impact on operations.
As of May 10, 1999, the Company has spent approximately $55,000 on the
project. The total cost of the project is expected to be approximately $75,000.
This includes replacing non-compliant hardware and software. It also includes
the internal human resource time to conduct systems and vendor surveys and
implement the required
-8-
<PAGE>
changes to become year 2000 compliant. Management believes that this
expenditure is not material to the Company and will not adversely impact
Chromaline's financial condition or liquidity.
Chromaline faces risk to the extent that suppliers of products and
services purchased by the Company and others with whom it transacts business on
a world-wide basis do not have business products and services that are year 2000
compliant. The Company distributed a survey to its suppliers during the second
quarter of 1999 regarding their state of readiness for the year 2000. As of May
10, 1999, the Company has received responses from 74% of its major suppliers,
all of which gave assurances that they will be year 2000 compliant. In the event
that a significant number of these third parties cannot, in a timely manner,
provide the Company with products and services because of the year 2000 issue,
Chromaline's operating results could be materially adversely affected.
The Company is addressing contingency plans in the event of year 2000
disruptions. With respect to the Company's internal production and
administrative systems, the Company believes sufficient alternative plans are in
place to adequately conduct business. These plans include the identification of
back-up and manual systems necessary to conduct normal business operations.
While Chromaline believes that its year 2000 project and contingency plans are
sufficient, there can be no assurance that the year 2000 will not materially
adversely affect its business, operating results or financial condition.
FUTURE OUTLOOK
Chromaline has invested over 6% of sales dollars for the past several
years on research and development. The Company plans to expand its efforts in
this area and expedite internal product development as well as form
technological alliances with outside experts to ensure the commercialization of
new product opportunities. In addition to its film, emulsion and self-adhesive
products, Chromaline's research and development efforts will also focus on
improving the efficiency of its automated photo developers for the decorative
sand blasting product line. The Company will also be looking at natural adjuncts
to its product line if extremely reliable sources of supply can be obtained and
resale margins are acceptable.
In addition to its traditional emphasis on domestic markets, the
Company will continue efforts to grow its business internationally by attempting
to develop new markets and expanding its market share where it has already
established a presence.
In its search for new opportunities, Chromaline will actively
investigate experimental technology sharing, joint ventures, and acquisitions to
complement its core strengths of innovative technology and recognized market
presence.
ITEM 3. DESCRIPTION OF PROPERTY
The Company conducts its entire operations in Duluth, Minnesota. The
administrative, sales, research and development, quality and manufacturing
activities are housed in a 60,000 square-foot four-story building, including a
basement level. The building is approximately seventy years old and has been
maintained in good condition. Shipping and distribution for the Company operates
from a three-year old 5,625 square-foot warehouse adjacent to the existing plant
building. These facilities are owned by the Company with no existing liens or
leases.
ITEM 4. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth, as of May 10, 1999, the number of
shares of Common Stock beneficially owned by each person who is a beneficial
owner of more than 5% of the outstanding Common Stock of the Company, by each
officer named in the Summary Compensation Table, by each director, and by all
officers and directors as a group. All persons have sole voting and dispositive
power over such shares unless otherwise indicated.
-9-
<PAGE>
<TABLE>
<CAPTION>
NAME AND ADDRESS NUMBER PERCENTAGE OF
OF BENEFICIAL OWNER: OF SHARES OUTSTANDING SHARES
- --------------------------------------------- ----------------------------------- --------------------------------
<S> <C> <C>
Directors and executive officers:
William C. Ulland 130,500(1) 11.0%
Philip J. Hourican 5,500 *
Charles H. Andresen 6,870(2) *
Gerald W. Simonson 55,200 4.7
David O. Harris 42,817 3.6
Thomas L. Erickson (retired July 1998) 69,775(3) 5.9
All directors and executive officers as 329,112(4) 27.7
a group (9 persons, including those
named above)
Other beneficial owners:
Leigh Severance 115,192(5) 9.7
</TABLE>
- ------------------
* Less than one percent.
(1) Includes options to purchase 3,000 shares of Common Stock exercisable
within 60 days of May 10, 1999. The address of Mr. Ulland is 740 East
Superior Street, Duluth, Minnesota 55802.
(2) Includes options to purchase 250 shares of Common Stock exercisable
within 60 days of May 10, 1999.
(3) Mr. Erickson held office as President and Chief Executive Officer, and
as a Director, until his retirement, effective July 12, 1998. The
address of Mr. Erickson is 20 South 26th Avenue East, Duluth, MN 55812.
(4) Includes options to purchase 9,750 shares of Common Stock exercisable
within 60 days of May 10, 1999.
(5) The address of Mr. Severance is 100 Filmore Street, Suite 300, Denver,
CO 80206.
ITEM 5. DIRECTORS, EXECUTIVE OFFICERS AND SIGNIFICANT EMPLOYEES OF THE
REGISTRANT
The Directors, Executive Officers and Significant Employees of the
Company are as follows:
<TABLE>
<CAPTION>
Name Age Position
--------------------- --------- ----------------------------------------------------
<S> <C> <C>
William C. Ulland 58 Chairman of the Board of Directors
Philip J. Hourican 55 President, Chief Executive Officer and Director
Jeffery A. Laabs 45 Vice President of Finance, Controller, Treasurer and
Secretary
Claude P. Piguet 41 Vice President of Operations
Toshifumi Komatsu 44 Vice President of Technology
Robert D. Banks, Jr. 47 Vice President of International Sales
Charles H. Andresen 58 Director
Gerald W. Simonson 68 Director
David O. Harris 64 Director
</TABLE>
-10-
<PAGE>
WILLIAM C. ULLAND has been a director and Chairman of the Board of the
Company since 1972. Since 1977, Mr. Ulland has been Managing Partner of American
Shield Company, a mineral exploration and development company located in Duluth,
Minnesota.
PHILIP J. HOURICAN has been President and Chief Executive Officer of
the Company since July 1998. He was elected to the Board of Directors shortly
thereafter. Mr. Hourican came to the Company from Balchem Corporation of Slate
Hill, New York. At Balchem, Mr. Hourican served as Vice President and General
Manager from July 1996 to February 1998. Balchem is an international marketer of
repackaged chemicals. From October 1994 to July 1996, Mr. Hourican was the Vice
President of Sales and Marketing on a nationwide basis for Techalloy, a
manufacturer of stainless steel and nickel wire located in Mahwah, New Jersey.
Mr. Hourican was a senior manager for Crosfield Chemicals, a manufacturer of
silicas, silicates, zeolites and catalysts located in Joliet, Illinois, from May
1988 to October 1994. Mr. Hourican received a B.S. in Chemical Engineering from
the University of Pittsburgh in 1967 and an M.B.A. from the University of Akron
in 1972.
JEFFERY A. LAABS, CMA has been Vice President of Finance and Controller
of the Company since May 1998. He was named Treasurer and Secretary of the
Company shortly thereafter. Mr. Laabs was a Senior Financial Analyst for Lake
Superior Paper Industries ("LSPI") in Duluth, Minnesota from September 1986
until he joined Chromaline in 1998. LSPI is a manufacturer of supercalendered
paper for newspaper inserts and magazines. His prior experience includes various
financial positions with Kimberly Clark Corporation, a manufacturer of paper
products, from September 1981 until September 1986. Mr. Laabs received a
Bachelor of Science degree in Accounting from Lake Superior State University in
1976. He earned the designation of Certified Management Accountant in 1996.
CLAUDE P. PIGUET has been the Company's Vice President of Operations
since May 1994. Previously, he was the Company's Director of Operations from
January 1992 to May 1994. Mr. Piguet joined Chromaline in 1990 and holds a
diploma of Engineer ETS/HTL from the Ecole D'Ingenieurs de l'Etat de Vaud in
Switzerland.
TOSHIFUMI KOMATSU has been the Company's Vice President of Technology
since September 1993. Previously, he served as Chromaline's Director of Research
and Development for two years. Mr. Komatsu has been with Chromaline's Research
and Development Department for 15 years. His prior experience includes positions
in research and development at Alberta Gas Chemicals, a manufacturer of organic
acids. He received a B.S. in Chemistry and Mathematics from the College of Saint
Scholastica in 1980.
ROBERT D. BANKS, JR. has been the Company's Vice President of
International Sales since February 1997. Previously, he was the Company's
Director of International Sales and Marketing from 1989 to 1997.
CHARLES H. ANDRESEN was elected as a director of the Company in 1979.
Mr. Andresen has been a shareholder in the law firm of Magie, Andresen, Haag,
Paciotti, Butterworth & McCarthy, P.A., in Duluth, Minnesota for more than the
past five years.
GERALD W. SIMONSON was elected as a director of the Company in 1978. He
has been the President of Omnetics Connector Corporation, a manufacturer of
microminiature connectors for the electronics industry located in Minneapolis,
Minnesota, for more than the past five years. Mr. Simonson is also a director of
Medtronic, Inc., a manufacturer of medical devices, and Northwest
Teleproductions, Inc., a film and video production company.
DAVID O. HARRIS was elected a director of the Company in 1965. He has
been President of David O. Harris, Inc., a manufacturer's representative firm in
Minneapolis, Minnesota, for more than the past five years.
ITEM 6. EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION
The following table sets forth certain information regarding
compensation earned by the individuals who served as Chief Executive Officer of
the Company during the fiscal years ended December 31, 1998, 1997 and 1996.
-11-
<PAGE>
No other executive officers of the Company received remuneration exceeding
$100,000 for the fiscal year ended December 31, 1998.
SUMMARY COMPENSATION TABLE
<TABLE>
<CAPTION>
LONG-TERM
COMPENSATION
AWARDS
ANNUAL -------------
COMPENSATION SHARES
------------------------ UNDERLYING ALL OTHER
NAME AND PRINCIPAL POSITION YEAR SALARY(1) BONUS OPTIONS(2) COMPENSATION(3)
- ------------------------------------ ---- ----------- ------- ------------ -----------------
<S> <C> <C> <C> <C> <C>
Philip J. Hourican 1998 $ 55,400 $ 2,990 20,526 $ 32,496
President and Chief Executive
Officer
Thomas L. Erickson, 1998 66,635 31,853 2,000 165,000
President and Chief Executive 1997 110,000 41,474 2,000 -
Officer 1996 102,500 41,786 2,000 -
</TABLE>
- ---------------
(1) Mr. Hourican joined the Company as President and Chief Executive
Officer on July 13, 1998. If he had been employed for all for 1998, his
salary would have been $120,000. Mr. Erickson retired from the Company
effective July 12, 1998.
(2) Represents options to purchase Common Stock granted under the Company's
1995 Stock Incentive Plan.
(3) Amounts reported for Mr. Hourican in 1998 represent payments made for
reimbursement of moving and temporary living expenses. Amounts reported
for Mr. Erickson in 1998 represent the following payments made in
connection with his retirement: a $65,000 severance payment, $80,000 in
consulting fees and $20,000 paid pursuant to Mr. Erickson's agreement
not to compete with the Company. The agreements governing the payments
to Mr. Erickson are discussed below under "Employment Agreements and
Termination of Employment and Change-in-Control Arrangements."
OPTION GRANTS IN LAST FISCAL YEAR
The following table summarizes option grants made during 1998 to the
Chief Executive Officer of the Company.
<TABLE>
<CAPTION>
INDIVIDUAL GRANTS
----------------------------------------------------------
PERCENTAGE POTENTIAL REALIZABLE VALUE
NUMBER OF OF TOTAL AT ASSUMED ANNUAL RATES
SHARES OPTIONS OF STOCK APPRECIATION FOR
UNDERLYING GRANTED TO EXERCISE OPTION TERM(1)
OPTIONS EMPLOYEES IN PRICE PER EXPIRATION -------------------------
NAME GRANTED(2) FISCAL YEAR SHARE DATE 5% 10%
- ------------------------- ---------- -------------- ----------- ----------- -------------------------
<S> <C> <C> <C> <C> <C> <C>
Philip J. Hourican 20,526 87.2% $9.50 7/13/05 $274,380 $379,991
</TABLE>
- -------------
(1) The potential realizable value is based on a 7-year term of each option
at the time of grant. Assumed stock price appreciation of 5% and 10% is
mandated by rules of the Securities and Exchange Commission and is not
intended to forecast actual future financial performance or possible
future appreciation. The potential realizable value is calculated by
assuming that the fair market value of the Company's Common Stock on
the date of grant
-12-
<PAGE>
appreciates at the indicated rate for the entire term of the option
and that the option is exercised at the exercise price and sold on
the last day of its term at the appreciated price.
(2) Options granted pursuant to the Company's 1995 Stock Incentive Plan are
exercisable at an exercise price equal to the fair market value on the
date of grant. The 20,526 share option granted to Mr. Hourican at $9.50
per share vests in three equal increments on the day prior to the
first, second and third anniversaries of the date of grant. This option
has a maximum term of seven years, subject to earlier termination in
the event of Mr. Hourican's cessation of service with the Company.
AGGREGATED OPTION
EXERCISES IN FISCAL 1998
AND FISCAL YEAR-END OPTION VALUES
The purpose of the following table is to report exercise of stock
options by the Chief Executive Officers of the Company during 1998 and the value
of his unexercised stock options as of December 31, 1998.
<TABLE>
<CAPTION>
NUMBER OF SHARES VALUE OF UNEXERCISED
UNDERLYING UNEXERCISED IN-THE-MONEY OPTIONS
OPTIONS AT FISCAL YEAR-END AT FISCAL YEAR-END(1)
SHARES -------------------------- ---------------------
ACQUIRED VALUE
NAME ON EXERCISE REALIZED EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE
- ------------------------ ----------- -------- ----------- ------------- ----------- -------------
<S> <C> <C> <C> <C> <C> <C>
Philip J. Hourican - - - 20,526 - $0
</TABLE>
- -----------
(1) Value is based on the per share closing price of the Company's Common
Stock on December 31, 1998, which was $7.50.
EMPLOYMENT AGREEMENTS AND TERMINATION OF EMPLOYMENT AND CHANGE-IN-CONTROL
ARRANGEMENTS
Thomas L. Erickson retired from his position as President and Chief
Executive Officer of the Company on July 12, 1998 and entered into a Separation
Agreement with the Company effective July 13, 1998. The Separation Agreement
provides for severance compensation of $65,000 which was paid during 1998. Mr.
Erickson also entered into an Agreement regarding Non-Disclosure of Confidential
Information and Non-Competition with the Company dated July 22, 1998. Pursuant
to this Agreement, Mr. Erickson has agreed not to compete with the Company prior
to December 31, 2002 in exchange for payments totaling $123,500 over the term of
the Agreement. Finally, Mr. Erickson agreed to act as a consultant to the
Company until December 31, 1999 and entered into a Consulting Agreement with the
Company dated July 22, 1998 providing for compensation of $80,000, all of which
was paid in 1998.
DIRECTOR COMPENSATION
During 1998, each non-employee director of the Company who beneficially
owns not more than 5% of the Company's outstanding Common Stock received a
one-time grant of an option to purchase 3,000 shares of the Company's Common
Stock under the 1995 Stock Incentive Plan. These options have an exercise price
equal to the fair market value on the date of grant and will expire seven years
from the date of grant. In addition, each non-employee director of the Company
who beneficially owns not more than 5% of the Company's outstanding Common Stock
receives a quarterly retainer of $1,000, plus per meeting fees of $700 for each
meeting of the Board of Directors attended in person, $350 for each meeting of
the Board of Directors attended by telephone, $300 for each committee meeting
attended in person and $150 for each committee meeting attended by telephone.
-13-
<PAGE>
On April 26, 1999, each non-employee director of the Company who
beneficially owns not more than 5% of the Company's outstanding Common Stock
received a one-time grant of an option to purchase 1,200 shares of the Company's
Common Stock under the 1995 Stock Incentive Plan. These options have an exercise
price equal to the fair market value on the date of the grant and will expire
seven years from the date of the grant. William C. Ulland also received a grant
of an incentive stock option to purchase 3,000 shares of the Company's Common
Stock under the 1995 Stock Incentive Plan in connection with his position as
Chairman of the Board of Directors. Mr. Ulland's options have an exercise price
equal to 110% of the fair market value on the date of the grant and will expire
five years from the date of the grant.
ITEM 7. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Not applicable.
ITEM 8. DESCRIPTION OF SECURITIES
GENERAL
The Company's Restated Articles of Incorporation, as amended, authorize
the issuance of up to 5,000,000 shares of capital stock. The shares are
classified into two classes, consisting of 4,750,000 shares of Common Stock,
$.10 par value, and 250,000 shares of Preferred Stock, $.10 par value.
The Board of Directors is authorized to establish one or more series of
Preferred Stock by resolution, set forth the designation of each such series and
fix the relative rights and preferences of each such series, provided that
certain voting, dividend and liquidation terms specified in the Restated
Articles of Incorporation may not be altered by the Board.
COMMON STOCK
At May 10, 1999, there were 1,180,061 shares of Common Stock issued and
outstanding and held by approximately 450 shareholders of record. Holders of
Common Stock are entitled to one vote per share for the election of directors
and on all matters submitted to a vote of shareholders, and there are no
cumulative voting rights for the election of directors. Holders of Common Stock
are entitled to receive dividends as and when declared by the Board of Directors
out of funds legally available therefor. Holders of Common Stock are not
entitled to preemptive rights. In the event of the liquidation, dissolution or
winding up of the Company, the holder of each share of Common Stock is entitled
to share equally in any balance of the Company's assets available for
distribution to shareholders after the holders of any Preferred Stock have
received the full distribution to which such holders are entitled. Outstanding
shares of Common Stock are not subject to any further call or assessment.
PREFERRED STOCK
The Company does not currently have any issued and outstanding shares
of Preferred Stock. Pursuant to the Company's Articles of Incorporation, the
Board of Directors has the authority, without further action by the
shareholders, to issue up to 250,000 shares of Preferred Stock in one or more
classes or series. The Board is authorized to determine the designation of and
number of shares in each series and to fix the dividend, redemption,
liquidation, retirement and conversion rights, if any, of such series, and any
other rights and preferences thereof, subject to certain limitations in the
Company's Restated Articles of Incorporation. These limitations state that
holders of the Company's Preferred Stock shall not have any voting rights unless
required by Minnesota law, shall be paid all accumulated or accrued dividends
prior to a dividend being declared or paid on the Company's Common Stock and
shall be entitled to receive the liquidation price of their Common Stock and any
accrued dividends thereon prior to any distributions being made to the holders
of Common Stock in the event of the liquidation, dissolution or winding up of
the Company. Any shares of Preferred Stock which may be issued may have greater
rights in many areas than the Common Stock, including preferences as to payment
of dividends and upon liquidation, and may be convertible into shares of Common
Stock. Preferred Stock could be issued quickly with terms calculated to delay or
prevent a change in control of the Company or make removal of management more
difficult. Additionally, the issuance of Preferred Stock may have the
-14-
<PAGE>
effect of decreasing the market price of the Common Stock, and may adversely
affect the rights of the holders of Common Stock. The Company has no present
plans to issue shares of Preferred Stock.
OPTIONS
At May 10, 1999, the Company had outstanding options to purchase up to
an aggregate of 76,776 shares of Common Stock to directors, officers and
employees of the Company at exercise prices ranging from $4.04 to $10.13 per
share.
ANTI-TAKEOVER PROVISIONS OF THE MINNESOTA BUSINESS CORPORATION ACT; RESTATED
ARTICLES OF INCORPORATION
Certain provisions of Minnesota law and the Company's Restated Articles
of Incorporation described below could have an anti-takeover effect. These
provisions are intended to provide management flexibility to enhance the
likelihood of continuity and stability in the composition of the Company's Board
of Directors and in the policies formulated by the Board and to discourage an
unsolicited takeover of the Company, if the Board determines that such a
takeover is not in the best interests of the Company and its shareholders.
However, these provisions could have the effect of discouraging certain attempts
to acquire the Company which could deprive the Company's shareholders of
opportunities to sell their shares of Common Stock at prices higher than
prevailing market prices.
Section 302A.671 of the Minnesota Statutes applies, with certain
exceptions, to any acquisitions of voting stock of the Company (from a person
other than the Company, and other than in connection with certain mergers and
exchanges to which the Company is a party) resulting in the beneficial ownership
of 20% or more of the voting stock then outstanding. Section 302A.671 requires
approval of the granting of voting rights for the shares received pursuant to
any such acquisition by a majority vote of the shareholders of the Company. In
general, shares acquired without such approval are denied voting rights and are
redeemable at their then fair market value by the Company within 30 days after
the acquiring person has failed to deliver a timely information statement to the
Company or the date the shareholders voted not to grant voting rights to the
acquiring person's shares.
Section 302A.673 of the Minnesota Statutes generally prohibits any
business combination by the Company, or any subsidiary of the Company, with any
shareholder which purchases 10% or more of the Company's voting shares (an
"interested shareholder") within four years following such interested
shareholder's share acquisition date, unless the business combination is
approved by a committee of all of the disinterested members of the Board of
Directors of the Company before the interested shareholder's share acquisition
date.
In addition, the existence of undesignated Preferred Stock in the
Restated Articles of Incorporation allows the Board of Directors of the Company,
without further shareholder action, to issue Preferred Stock with certain rights
and in amounts that could have the effect of making it more difficult for a
third party to acquire, or of discouraging a third party from acquiring, control
of the Company.
TRANSFER AGENT AND REGISTRAR
Norwest Bank Minnesota, National Association, is the transfer agent and
registrar for the Company's Common Stock.
PART II
ITEM 1. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
The Company's Common Stock is traded on the local over-the-counter
market in the Minneapolis-St. Paul area under the symbol CMLH. The following
table sets forth, for the fiscal quarters indicated, the high and low bid prices
for the Company's Common Stock as reported on the local over-the-counter market
in the Minneapolis-St. Paul area. The quotations reflect inter-dealer prices
without retail mark-up, mark-down or commission, and may not represent actual
transactions.
-15-
<PAGE>
<TABLE>
<CAPTION>
HIGH LOW
------ ------
<S> <C> <C>
FISCAL YEAR ENDED DECEMBER 31, 1999:
First Quarter............................................................ $ 7.75 $ 6.75
Second Quarter (through May 24, 1999).................................... 9.25 8.00
FISCAL YEAR ENDED DECEMBER 31, 1998:
First Quarter............................................................ $ 8.88 $ 7.00
Second Quarter........................................................... 9.00 7.38
Third Quarter............................................................ 10.38 7.75
Fourth Quarter........................................................... 8.06 7.00
FISCAL YEAR ENDED DECEMBER 31, 1997:
First Quarter............................................................ $ 6.67 $ 5.00
Second Quarter........................................................... 9.00 6.00
Third Quarter............................................................ 10.17 8.00
Fourth Quarter........................................................... 10.00 8.50
</TABLE>
As of May 10, 1999, the Company had approximately 450 shareholders of
record. The Company has never declared or paid any dividends on its Common
Stock. The Company currently intends to retain any earnings for use in its
business and therefore does not anticipate paying any dividends in the near
future.
ITEM 2. LEGAL PROCEEDINGS
On October 22, 1996, Aicello North America, Inc., a Canadian
corporation ("ANA"), filed suit against the Company in the United States
District Court for the Western District of Washington, alleging infringement by
the Company of U.S. Patent No. 5,427,890 (the "890 patent"). Later, ANA added
U.S. Patent No. 5,629,132 (the "132 patent") to the lawsuit. The 890 patent and
the 132 patent had been assigned to Aicello Chemical Co. Ltd. of Japan ("ACLJ")
on October 22, 1996 and were licensed to ANA shortly before filing of the
present infringement action. At Chromaline's request, ACLJ was joined to the
suit. The subjects of the patents and the allegedly infringing Chromaline
products are three-layer photosensitive films used to engrave patterns or
designs into hard surfaces such as metal, glass, stone and wood.
The Company and ANA attempted to settle the suit with two mediation
sessions that did not result in a settlement. Following these mediations,
Chromaline requested in August 1998 that the U.S. Patent and Trademark Office
("USPTO") reexamine the 890 patent and the 132 patent. This request was granted
as to both patents in November 1998 and the lawsuit was stayed pending this
review. The reexamination process will require approximately twelve to eighteen
months to complete. A favorable ruling by the USPTO may result in the dismissal
of the case. In the USPTO's OFFICE ACTION IN REEXAMINATION dated February 23,
1999, the USPTO initially rejected the plaintiff's claims of patent
infringement. The OFFICE ACTION required the ANA and ACLJ to respond within 60
days, which they have done. The Company is waiting for the USPTO's subsequent
OFFICE ACTION, which is expected within a few months of the USPTO's receipt of
the ANA and ACLJ responses.
The Company has made provisions to cover certain legal proceedings and
related costs and expenses as described in note 2 to its audited financial
statements included herein. However, the ultimate outcome and materiality of
these matters cannot be determined. Accordingly, no provision for any liability
that may result therefrom has been made in the audited financial statements.
ITEM 3. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
Not applicable.
-16-
<PAGE>
ITEM 4. RECENT SALES OF UNREGISTERED SECURITIES
During the past three years the Company has sold the following
securities pursuant to exemptions from registration under the Securities Act of
1933, as amended (the "Act"). The sales referred to below were all made in
reliance upon the exemptions from registration provided by Rule 701 under the
Act for securities sold pursuant to certain compensatory benefit plans and
contracts relating to compensation, and related state securities laws. All
shares were issued directly by the Company, no underwriters were involved, and
no discount, commission or transaction-related remuneration was paid.
1. On February 18, 1997, the Company granted options to purchase an
aggregate of 3,750 shares of the Company's Common Stock at
$5.6667 per share to four of the Company's employees.
2. On June 15, 1998, the Company granted an option to purchase an
aggregate of 3,000 shares of the Company's Common Stock at
$8.625 per share to an executive officer of the Company.
3. On July 13, 1998, the Company granted an option to purchase an
aggregate of 20,526 shares of the Company's Common Stock at
$9.50 per share to an executive officer of the Company.
4. On August 19, 1998, the Company granted options to purchase an
aggregate of 9,000 shares of the Company's Common Stock at
$10.125 per share to three of the Company's directors.
5. On April 26, 1999, the Company granted options to purchase an
aggregate of 24,500 shares of the Company's Common Stock at
$9.00 per share to fifteen of the Company's employees, five of
the Company's officers and three of the Company's directors. On
the same date, the Company granted an option to purchase an
aggregate of 3,000 shares of the Company's Common Stock at $9.90
per share to the Chairman of the Company's Board of Directors.
ITEM 5. INDEMNIFICATION OF DIRECTORS AND OFFICERS
Under Article V, Sections 1 and 2 of the Company's By-Laws, as amended,
and Article VIII, Section 8.5 of the Company's Restated Articles of
Incorporation, as amended, the Company indemnifies its directors and officers
and advances litigation expenses to the fullest extent required or permitted by
Minnesota Statutes Section 302A.521. This indemnification is subject to the
requirement in the case of legal judgments, that the individual seeking
indemnification is not finally adjudged to have been guilty of willful
misconduct detrimental to the best interests of the Company. Section 302A.521
requires the Company to indemnify a person made or threatened to be made a party
to a proceeding, by reason of the former or present official capacity of the
person with respect to the Company, against judgments, penalties, fines,
including without limitation, excise taxes assessed against the person with
respect to an employee benefit plan, settlements, and reasonable expenses,
including attorneys' fees and disbursements, if, with respect to the acts or
omissions of the person complained of in the proceeding, such person (1) has not
been indemnified by another organization or employee benefit plan for the same
judgments, penalties, fines, including without limitation, excise taxes assessed
against the person with respect to an employee benefit plan, settlements, and
reasonable expenses, including attorneys' fees and disbursements, incurred by
the person in connection with the proceeding with respect to the same acts or
omissions; (2) acted in good faith; (3) received no improper personal benefit,
and statutory procedure has been followed in the case of any conflict of
interest by a director; (4) in the case of a criminal proceeding, had no
reasonable cause to believe the conduct was unlawful; and (5) in the case of
acts or omissions occurring in the person's performance in the official capacity
of director or, for a person not a director, in the official capacity of
officer, committee member, employee or agent, reasonably believed that the
conduct was in the best interests of the Company, or in the case of performance
by a director, officer, employee or agent of the Company as a director, officer,
partner, trustee, employee or agent of another organization or employee benefit
plan, reasonably believed that the conduct was not opposed to the best interests
of the Company. In addition, Section 302A.521, subd. 3, requires payment by the
Company upon written request, of reasonable expenses in advance of final
disposition in certain instances.
-17-
<PAGE>
The Restated Articles of Incorporation of the Company, as amended,
eliminate the personal liability of a director to the Company or its
shareholders for monetary damages for breach of fiduciary duty as a director,
except under certain circumstances involving any breach of the director's duty
of loyalty to the Company or its shareholders, acts or omissions not in good
faith or that involve intentional misconduct or a knowing violation of law, or
for any unlawful acts under Sections 302A.559 or 80A.23 of Minnesota Statutes.
PART F/S
<TABLE>
<CAPTION>
INDEX TO FINANCIAL STATEMENTS
PAGE NUMBER
-----------
<S> <C>
Independent Auditors' Report 19
Balance Sheets as of December 31, 1998 and 1997 and
March 31, 1999 (unaudited) 20
Statements of Earnings for the Years Ended December 31, 1998 and 1997
and for the Three Months Ended March 31, 1998 (unaudited) and and
1999 (unaudited) 21
Statements of Stockholders' Equity for the Years Ended
December 31, 1998 and 1997 and for the Three Months Ended
March 31, 1999 (unaudited) 22
Statements of Cash Flows for the Years Ended December 31, 1998 and 1997
and the Three Months Ended March 31, 1999 (unaudited)
and 1998 (unaudited) 23
Notes to Financial Statements 24
</TABLE>
-18-
<PAGE>
INDEPENDENT AUDITORS' REPORT
Stockholders and Board of Directors
The Chromaline Corporation
We have audited the accompanying balance sheets of The Chromaline Corporation
(the Company) as of December 31, 1998 and 1997 and the related statements of
earnings, stockholders' equity, and cash flows for the years ended December 31,
1998 and 1997. These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on these
financial statements based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of The Chromaline Corporation as
of December 31, 1998 and 1997 and the results of its operations and its cash
flows for the years ended December 31, 1998 and 1997, in conformity with
generally accepted accounting principles.
/s/ Deloitte & Touche LLP
Minneapolis, Minnesota
January 15, 1999
-19-
<PAGE>
<TABLE>
<CAPTION>
THE CHROMALINE CORPORATION
BALANCE SHEETS
- ----------------------------------------------------------------------------------------------------------------------------------
DECEMBER 31
MARCH 31 -----------------------------
1999 1998 1997
(UNAUDITED)
<S> <C> <C> <C>
ASSETS
CURRENT ASSETS:
Cash and cash equivalents $ 478,957 $ 274,757 $ 732,381
Trade receivables, less allowance for doubtful accounts of
$14,400, $14,400, and $14,700, respectively 1,246,789 1,128,568 1,201,146
Trade receivable from related party 251,741 271,443 235,116
Inventories 1,065,456 1,255,192 966,458
Prepaid expenses and other assets 245,074 97,409 41,338
Marketable securities 507,680 508,445
Income tax refund receivable 61,801 61,801
Deferred taxes (Note 4) 54,000 54,000 128,000
---------- ---------- ----------
Total current assets 3,911,498 3,651,615 3,304,439
PROPERTY, PLANT, AND EQUIPMENT, at cost:
Land and building 1,171,560 1,171,560 1,045,560
Machinery and equipment 2,013,715 1,991,566 1,856,700
Office equipment 518,254 516,935 463,350
Vehicles 199,335 199,335 165,678
---------- ---------- ----------
3,902,864 3,879,396 3,531,288
Less accumulated depreciation 2,553,600 2,455,816 2,109,752
---------- ---------- ----------
1,349,264 1,423,580 1,421,536
PATENTS, net of amortization of $8,194, $5,752, and $0, respectively 101,273 103,715
OTHER 38,733 38,733 38,733
DEFERRED TAXES (Note 4) 43,000 43,000 17,000
---------- ---------- ----------
$5,443,768 $5,260,643 $4,781,708
---------- ---------- ----------
---------- ---------- ----------
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Note payable, bank $ 21,897
Accounts payable $ 180,768 $ 207,813 228,808
Accrued expenses 195,862 129,673 281,752
Accrued legal costs (Note 3) 61,692 63,324 250,000
Income taxes payable 106,109
---------- ---------- ----------
Total current liabilities 438,322 400,810 888,566
CONTINGENCIES (Note 3)
STOCKHOLDERS' EQUITY:
Preferred stock, par value $.10 per share; authorized 250,000 shares;
issued none
Common stock, par value $.10 per share; authorized 4,750,000 shares; issued
and outstanding 1,178,811, 1,178,311, and
1,161,061 shares, respectively 117,881 117,831 116,107
Additional paid-in capital 410,795 408,225 323,789
Retained earnings 4,476,770 4,333,777 3,453,246
---------- ---------- ----------
Total stockholders' equity 5,005,446 4,859,833 3,893,142
---------- ---------- ----------
$5,443,768 $5,260,643 $4,781,708
---------- ---------- ----------
---------- ---------- ----------
</TABLE>
See notes to financial statements.
-20-
<PAGE>
THE CHROMALINE CORPORATION
STATEMENTS OF EARNINGS
<TABLE>
<CAPTION>
THREE MONTHS YEARS ENDED
ENDED MARCH 31, DECEMBER 31,
---------------------------- ------------------------------
1999 1998 1998 1997
(UNAUDITED)
<S> <C> <C> <C> <C>
SALES $2,236,725 $2,343,227 $9,289,328 $8,899,849
COSTS AND EXPENSES:
Cost of goods sold 1,061,908 1,089,896 4,193,050 4,178,797
Selling, general, and administrative 789,183 713,490 3,072,636 2,672,986
Research and development 161,998 157,206 679,734 603,521
Patent litigation costs (Note 3) 445,000
---------- ---------- ---------- ----------
2,013,089 1,960,592 7,945,420 7,900,304
---------- ---------- ---------- ----------
INCOME FROM OPERATIONS 223,636 382,635 1,343,908 999,545
INTEREST INCOME 3,257 7,111 28,623 9,830
---------- ---------- ---------- ----------
INCOME BEFORE INCOME TAXES 226,893 389,746 1,372,531 1,009,375
FEDERAL AND STATE INCOME
TAXES (Note 4) 83,900 148,000 492,000 371,000
---------- ---------- ---------- ----------
NET INCOME $ 142,993 $ 241,746 $ 880,531 $ 638,375
---------- ---------- ---------- ----------
---------- ---------- ---------- ----------
BASIC EARNINGS PER
COMMON SHARE $ 0.12 $ 0.21 $ 0.75 $ 0.55
---------- ---------- ---------- ----------
---------- ---------- ---------- ----------
DILUTED EARNINGS PER
COMMON SHARE $ 0.12 $ 0.21 $ 0.75 $ 0.54
---------- ---------- ---------- ----------
---------- ---------- ---------- ----------
WEIGHTED AVERAGE NUMBER
OF COMMON SHARES
OUTSTANDING 1,170,153 1,162,039 1,169,689 1,160,297
---------- ---------- ---------- ----------
---------- ---------- ---------- ----------
WEIGHTED AVERAGE NUMBER
OF COMMON AND COMMON
EQUIVALENT SHARES
OUTSTANDING 1,186,134 1,177,230 1,178,613 1,178,730
---------- ---------- ---------- ----------
---------- ---------- ---------- ----------
</TABLE>
See notes to financial statements.
-21-
<PAGE>
THE CHROMALINE CORPORATION
STATEMENTS OF STOCKHOLDERS' EQUITY
<TABLE>
<CAPTION>
ADDITIONAL
COMMON PAID-IN RETAINED
STOCK CAPITAL EARNINGS TOTAL
<S> <C> <C> <C> <C>
BALANCE AT DECEMBER 31, 1996 $ 116,007 $ 319,849 $ 2,814,871 $ 3,250,727
Net income 638,375 638,375
Issuance of 1,000 shares of common stock
upon exercise of options 100 3,940 4,040
---------- ----------- ------------ ------------
BALANCE AT DECEMBER 31, 1997 116,107 323,789 3,453,246 3,893,142
Net income 880,531 880,531
Issuance of 12,000 shares of common stock
upon exercise of options 1,724 70,420 72,144
Tax benefit resulting from exercise of
options 14,016 14,016
---------- ----------- ------------ ------------
BALANCE AT DECEMBER 31, 1998 117,831 408,225 4,333,777 4,859,833
Net income, unaudited 142,993 142,993
Issuance of 500 shares of common stock
upon exercise of options, unaudited 50 1,970 2,020
Tax benefit resulting from exercise
of options, unaudited 600 600
---------- ----------- ------------ ------------
BALANCE AT MARCH 31, 1999 (unaudited) $ 117,881 $ 410,795 $ 4,476,770 $ 5,005,446
---------- ----------- ------------ ------------
---------- ----------- ------------ ------------
</TABLE>
See notes to financial statements.
-22-
<PAGE>
THE CHROMALINE CORPORATION
STATEMENTS OF CASH FLOWS
<TABLE>
<CAPTION>
THREE MONTHS YEARS ENDED
ENDED MARCH 31, DECEMBER 31,
----------------------------- -------------------------------
1999 1998 1998 1997
(UNAUDITED)
<S> <C> <C> <C> <C>
CASH FLOWS FROM OPERATING
ACTIVITIES:
Net income $ 142,993 $ 241,746 $ 880,531 $ 638,375
Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation and amortization 100,226 83,116 389,626 329,878
Loss on disposal of assets 11,452 5,079
Deferred income taxes 48,000 (100,000)
Changes in working capital components:
Decrease (increase) in:
Trade receivables (98,519) (108,817) 36,251 (83,638)
Prepaid expenses and other assets (147,665) 1,490 (56,071) 54,347
Inventories 189,736 (106,498) (288,734) 75,860
Income taxes refund receivable (47,785)
(Decrease) increase in:
Accounts payable (27,045) 101,769 (20,995) (147,438)
Accrued expenses 66,789 (125,022) (152,079) 250,000
Accrued legal costs (1,632) (10,804) (186,676) 14,568
Income taxes payable 62,054 (106,109) 80,109
------------- -------------- -------------- ---------------
Net cash provided by
operating activities 224,883 139,034 507,411 1,117,140
CASH FLOWS FROM INVESTING
ACTIVITIES:
Purchase of property and equipment (23,468) (67,195) (399,209) (445,502)
Proceeds on sale of property
and equipment 1,839 24,556
Purchases of marketable securities (909,429)
Proceeds from sale of marketable securities 765 400,984
Purchase of patents (109,467)
------------- -------------- -------------- ---------------
Net cash used in investing activities (22,703) (67,195) (1,015,282) (420,946)
CASH FLOWS FROM
FINANCING ACTIVITIES:
Payments on note payable (21,897) (21,897) (37,818)
Proceeds from exercise of stock options 2,020 4,041 72,144 4,040
------------- -------------- -------------- ---------------
Net cash provided by (used in)
financing activities 2,020 (17,856) 50,247 (33,778)
------------- -------------- -------------- ---------------
NET INCREASE (DECREASE) IN CASH
AND CASH EQUIVALENTS 204,200 53,983 (457,624) 662,416
CASH AND CASH EQUIVALENTS AT
BEGINNING OF PERIOD 274,757 732,381 732,381 69,965
------------- -------------- -------------- ---------------
CASH AND CASH EQUIVALENTS AT
END OF PERIOD $ 478,957 $ 786,364 $ 274,757 $ 732,381
------------- -------------- -------------- ---------------
------------- -------------- -------------- ---------------
SUPPLEMENTAL DISCLOSURES OF
CASH FLOW INFORMATION:
Cash payments for interest $ - $ 55 $ 55 $ 3,224
------------- -------------- -------------- ---------------
------------- -------------- -------------- ---------------
Cash payments for income taxes $ 30,000 $ 86,000 $ 598,000 $ 390,000
------------- -------------- -------------- ---------------
------------- -------------- -------------- ---------------
</TABLE>
See notes to financial statements.
-23-
<PAGE>
THE CHROMALINE CORPORATION
NOTES TO FINANCIAL STATEMENTS
THREE MONTHS ENDED MARCH 31, 1999 AND 1998 (unaudited)
AND YEARS ENDED DECEMBER 31, 1998 AND 1997
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
DESCRIPTION OF BUSINESS - The Chromaline Corporation (the Company)
develops and manufactures high-quality photochemical imaging systems for
sale primarily to a wide range of printers and decorators of surfaces.
Customers' applications include textiles, billboards, electronics,
glassware, fine china, and many other industrial and commercial
applications. The Company's principal markets are throughout the United
States. In addition, the Company sells to Western Europe, Latin America,
Asia, and other parts of the world. The Company extends credit to its
customers, all on an unsecured basis, on terms that it establishes for
individual customers.
Fifty-one percent and 44%, respectively, of the Company's accounts
receivable at December 31, 1998 and 1997 are due from foreign customers.
The foreign receivables are composed primarily of open credit
arrangements with terms ranging from 45 to 90 days. No receivable from a
single unrelated customer exceeded 10% of total accounts receivable at
March 31, 1999 and December 31, 1998 and 1997. No single customer
represented greater than 10% of total revenue.
A summary of the Company's significant accounting policies follows:
UNAUDITED FINANCIAL STATEMENTS - The financial statements as of March
31, 1999 and for the three months ended March 31, 1999 and 1998 are
unaudited. In the opinion of management, such unaudited financial
statements include all adjustments, consisting of only normal, recurring
accruals, necessary for a fair presentation thereof. The results of
operations for any interim period are not necessarily indicative of the
results for the year.
CASH AND CASH EQUIVALENTS - The Company considers all highly liquid debt
instruments purchased with a maturity of three months or less to be cash
equivalents. Cash equivalents consist of money market funds in which
carrying value approximates market value because of the short maturity
of these instruments.
INVENTORIES - Inventories are stated at the lower of cost (last-in,
first-out) or market.
DEPRECIATION - Depreciation of property and equipment is computed using
the straight-line method over the following estimated useful lives:
<TABLE>
<CAPTION>
YEARS
<S> <C>
Building 25
Machinery and equipment 5
Office equipment 5
Vehicles 3
</TABLE>
-24-
<PAGE>
IMPAIRMENT OF LONG-LIVED ASSETS - Management periodically reviews the
carrying value of long-term assets for potential impairment by comparing
the carrying value of these assets to the estimated undiscounted future
cash flows expected to result from the use of these assets. Should the
sum of the related, expected future net cash flows be less than the
carrying value, an impairment loss would be measured. An impairment loss
would be measured by the amount by which the carrying value of the asset
exceeds the fair value of the asset with fair value being determined
using discounted cash flows. To date, management has determined that no
impairment of these assets exists.
PATENTS - The Company purchased a patent in 1998 for $109,467.
Amortization of the patent is computed using the straight-line method
over its remaining estimated useful life of 13 years.
LEGAL COSTS - The Company accrues legal costs expected to be incurred in
connection with lawsuits in which the Company is the defendant. These
costs are accrued by the Company, on a case-by-case basis, in the period
during which the Company is able to estimate the probable amount of
future legal cost to be incurred with respect to a given matter.
REVENUE RECOGNITION - The Company recognizes revenue on products when
title passes, which is usually upon shipment.
INCOME TAXES - Deferred income taxes are provided on an asset and
liability method. Deferred tax assets and liabilities are adjusted for
the effects of changes in tax laws and rate on the date of enactment.
EARNINGS PER COMMON SHARE (EPS) - Basic EPS is calculated using income
available to common shareholders divided by the weighted average of
common shares outstanding during the year. Diluted EPS is similar to
Basic except that the weighted average of common shares outstanding is
increased to include the number of additional common shares that would
have been outstanding if the dilutive potential common shares, such as
options, had been issued.
Shares used in the calculation of diluted earnings per share are
summarized below:
<TABLE>
<CAPTION>
MARCH 31 DECEMBER 31
----------------------- ------------------------
1999 1998 1998 1997
<S> <C> <C> <C> <C>
Weighted Average Common Shares Outstanding 1,170,153 1,162,039 1,169,689 1,160,297
Dilutive Effect of Stock Options 15,981 15,191 8,924 18,433
--------- --------- --------- ---------
Weighted Average Common and Common
Equivalent Shares Outstanding 1,186,134 1,177,230 1,178,613 1,178,730
--------- --------- --------- ---------
--------- --------- --------- ---------
</TABLE>
USE OF ESTIMATES - The preparation of the financial statements in
conformity with generally accepted accounting principles requires
management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the financial statements and the reported
amounts of revenues and expenses during the reporting period. Actual
results could differ from those estimates.
MARKETABLE SECURITIES - Marketable securities consist of investments in
municipal revenue bonds with maturities of three years or less.
Marketable securities are classified as available for sale and
accordingly are recorded at fair market value. The unrealized
appreciation/depreciation of the marketable securities was not
significant at December 31, 1998 or 1997.
-25-
<PAGE>
STOCK OPTIONS - As described in Note 7, the Company has adopted only the
disclosure requirements of Statement of Financial Accounting Standards
(SFAS) No. 123, ACCOUNTING FOR STOCK-BASED COMPENSATION. Stock options
granted to employees and board members continue to be accounted for
under Accounting Principles Board Opinion No. 25.
FOREIGN OPERATIONS - The Company markets in Europe, Latin America, Asia,
and other parts of the world. Foreign sales approximated 35%, 39%, 32%,
and 29% of total sales in the three months ended March 31, 1999 and 1998
and the years ended December 31, 1998 and 1997, respectively. All
foreign revenues are denominated in U.S. dollars.
In December 1996, the Company purchased a 19.5% interest in Chromaline
Europe, S.A., a French corporation. On January 2, 1997, the Company sold
the assets of the French representative office to Chromaline Europe,
S.A. for an amount which approximated cost. In the three months ended
March 31, 1999 and 1998 and the years ended December 31, 1998 and 1997,
less than 10% of total sales were made through Chromaline Europe, S.A.
The Company accounts for its investment in Chromaline Europe, S.A., at
historical cost.
NOTE PAYABLE, BANK - The Company has a bank line of credit that provides
for up to $1,250,000 of working capital financing. This line of credit
is subject to annual renewal on each May 1, is collateralized by
inventory and trade receivables, and at December 31, 1998 bears interest
at 2.5 percentage points over 30-day LIBOR. The line of credit has been
extended to April 30, 2000. The outstanding balance at March 31, 1999,
and December 31, 1998 and 1997 was $0, $0, and $21,897, respectively.
ACCOUNTING PRONOUNCEMENT - In June 1997, the Financial Accounting
Standards Board issued SFAS No. 131, DISCLOSURE ABOUT SEGMENTS OF AN
ENTERPRISE AND RELATED INFORMATION, which changes the way public
companies report information about operating segments. SFAS No. 131,
which is based on the management approach to segment reporting,
establishes requirements to report selected segment information
quarterly and to report entitywide disclosures about products and
services, major customers, and material countries in which the entity
holds assets and reports revenue. The Company adopted SFAS No. 131 as of
December 31, 1998. The Company operates within a single operating
segment.
2. INVENTORIES
Components of inventories at March 31, 1999 and December 31, 1998 and
1997 were as follows:
<TABLE>
<CAPTION>
MARCH 31, DECEMBER 31,
1999 1998 1997
<S> <C> <C> <C>
Raw materials $ 462,630 $ 524,199 $ 511,435
Work-in-process 368,874 409,539 240,97
Finished goods 351,952 459,454 377,051
------------- -------------- ------------
1,183,456 1,393,192 1,129,458
Less allowance to reduce carrying value to
LIFO cost 118,000 138,000 163,000
------------- -------------- ------------
Total $ 1,065,456 $ 1,255,192 $ 966,458
------------- -------------- ------------
------------- -------------- ------------
</TABLE>
-26-
<PAGE>
If the first-in, first-out cost method had been used, inventories would
have been approximately $118,000, $138,000, and $163,000 higher than
reported at March 31, 1999 and December 31, 1998 and 1997, respectively.
3. CONTINGENCIES
The Company is a defendant in a claim filed in the United States
District Court, Western District of Washington at Seattle, in which the
claimant alleges that certain of the Company's products infringe on a
U.S. patent owned by the claimant. The Company has filed an answer
denying infringement and further believes the claimant's patent to be
invalid, and to have been procured through inequitable conduct. During
fiscal 1997, the Company incurred $445,000 of legal costs for this
matter, including a $250,000 accrual at December 31, 1997 to cover
future legal costs.
During fiscal 1998, the lawsuit was stayed after Chromaline filed a
Request for Reexamination with the United States Patent and Trademark
Office with respect to the patents involved in the suit. The request was
granted and the reexamination is presently ongoing. The reexamination is
not expected to be completed for 12 to 18 months. During the three
months ended March 31, 1999 and 1998 and the year ended December 31,
1998, the Company paid approximately $188,000 in legal and related costs
in the defense of this matter. Such payments were applied against the
accrual established at December 31, 1997. At March 31, 1999, the Company
had a remaining accrual of $61,700 for expected future legal costs
relating to this matter.
4. INCOME TAXES
Income tax expense for the three months ended March 31, 1999 and 1998
and the years ended December 31, 1998 and 1997 consists of the
following:
<TABLE>
<CAPTION>
THREE MONTHS ENDED YEARS ENDED
MARCH 31, DECEMBER 31,
--------------------------------- -----------------------------
1999 1998 1998 1997
<S> <C> <C> <C> <C>
Current:
Federal $ 75,000 $ 133,000 $ 399,000 $ 427,000
State 8,900 15,000 45,000 44,000
------------- ------------ ------------ ------------
83,900 148,000 444,000 471,000
Deferred 48,000 (100,000)
------------- ------------ ------------ ------------
$ 83,900 $ 148,000 $ 492,000 $ 371,000
------------- ------------ ------------ ------------
------------- ------------ ------------ ------------
</TABLE>
The expected provision for income taxes, computed by applying the U.S.
federal income tax rate of 35% to income before taxes, is reconciled to
income tax expense as follows:
<TABLE>
<CAPTION>
THREE MONTHS ENDED YEARS ENDED
MARCH 31, DECEMBER 31,
--------------------------------- -----------------------------
1999 1998 1998 1997
<S> <C> <C> <C> <C>
Expected provision for
federal income taxes $ 79,400 $ 136,200 $ 465,000 $ 346,000
State income taxes 4,900 10,500 30,000 44,000
-27-
<PAGE>
Research tax credits (21,000)
Foreign sales corporation (2,900) (500) (17,000) (12,000)
Meals and entertainment 1,700 1,000 10,000 8,000
Other 800 800 4,000 6,000
------------- ------------ ------------ ------------
$ 83,900 $ 148,000 $ 492,000 $ 371,000
------------- ------------ ------------ ------------
------------- ------------ ------------ ------------
</TABLE>
Deferred tax assets consist of the following as of March 31, 1999 and
December 31, 1998 and 1997:
<TABLE>
<CAPTION>
MARCH 31, DECEMBER 31,
1999 1998 1997
<S> <C> <C> <C>
Property and equipment $ 43,000 $ 43,000 $ 25,000
Accrued vacation 13,000 13,000 14,000
Inventory 10,000 10,000 9,000
Allowance for doubtful accounts 5,000 5,000 6,000
Allowance for sales returns 10,000 10,000 6,000
Accrued legal costs 23,000 23,000 95,000
Other (7,000) (7,000) (10,000)
--------------- ------------ ------------
$ 97,000 $ 97,000 $ 145,000
--------------- ------------ ------------
--------------- ------------ ------------
</TABLE>
5. PENSION PLAN
The Company has a defined contribution pension plan which covers
substantially all of its employees. The Company contributes an amount
equal to 5% of a covered employee's compensation. Total pension expense
for the three months ended March 31, 1999 and 1998, and for the years
ended December 31, 1998 and 1997 was approximately $34,000, $29,000,
$115,000, and $112,000, respectively.
5. GEOGRAPHIC INFORMATION
The Company manages its business on the basis of one reportable segment.
See Note 1 for a brief description of the Company's business. As of
December 31, 1998, the Company had operations established in various
countries throughout the world. The Company is exposed to the risk of
changes in social, political, and economic conditions inherent in
foreign operations and the Company's results of operations are affected
by fluctuations in foreign currency exchange rates. In no single country
did operations account for more than 10% of the Company's net sales for
the three months ended March 31, 1999 and 1998, and for the years ended
December 31, 1998 and 1997. Net sales by geographic area are presented
by attributing revenues from external customers on the basis of where
the products are sold.
<TABLE>
<CAPTION>
THREE MONTHS ENDED YEARS ENDED
MARCH 31, DECEMBER 31,
--------------------------------- ------------------------------
1999 1998 1998 1997
<S> <C> <C> <C> <C>
Net sales by geographic area:
United States $ 1,446,624 $ 1,415,373 $ 6,316,743 $ 6,318,893
International 790,101 927,854 2,972,585 2,580,956
--------------- -------------- -------------- -------------
$ 2,236,725 $ 2,343,227 $ 9,289,328 $ 8,899,849
--------------- -------------- -------------- -------------
--------------- -------------- -------------- -------------
</TABLE>
-28-
<PAGE>
7. STOCK OPTIONS
During 1995, the Company adopted a stock incentive plan for the issuance
of up to 35,000 shares of common stock. In 1997, the Company increased
the number of shares reserved for issuance under this plan to 70,000
shares. The plan provides for granting eligible participants stock
options or other stock awards, as described by the plan, at option
prices ranging from 85% to 110% of fair market value at date of grant.
Options granted expire up to ten years after the date of grant. Such
options become exercisable over a three-year period.
The Company has adopted the disclosure provisions of SFAS No. 123 and
has continued to apply APB Opinion No. 25 and related interpretation in
accounting for its plan. Accordingly, no compensation cost has been
recognized for its plan. Had compensation cost for the Company's
stock-based compensation plans been determined based on the fair value
at the grant dates as calculated in accordance with SFAS No. 123, the
Company's net income and earnings per share for the years ended December
31, 1998 and 1997 would have been reduced to the pro forma amounts
indicated below:
<TABLE>
<CAPTION>
YEARS ENDED
DECEMBER 31,
---------------------------
1998 1997
<S> <C> <C>
Net income:
As reported $ 880,531 $ 638,375
Pro forma 838,723 601,774
Net income per share (basic):
As reported $ 0.75 $ 0.55
Pro forma 0.72 0.52
Net income per share (diluted):
As reported $ 0.75 $ 0.54
Pro forma 0.71 0.51
</TABLE>
The fair value of each option grant is estimated on the date of grant
using the Black-Scholes option-pricing model with the following
weighted-average assumptions used for grants are as follows:
<TABLE>
<CAPTION>
YEARS ENDED
DECEMBER 31,
------------------------
1998 1997
<S> <C> <C>
Dividend yield - -
Expected volatility 52.2% 55.0%
Risk-free interest rate 5.5% 5.5%
Average expected life 7 years 7 years
</TABLE>
Based upon these assumptions, the weighted-average fair value at grant
date of options granted during the years ended December 31, 1998 and
1997 was $5.76 and $3.69, respectively.
-29-
<PAGE>
A summary of the status of the Company's stock option plan is presented
below:
<TABLE>
<CAPTION>
WEIGHTED
AVERAGE
NUMBER OF EXERCISE
SHARES PRICE
<S> <C> <C>
Outstanding at December 31, 1996 36,000 $ 4.06
Granted 3,750 5.67
Exercised (1,000) 4.04
Expired (1,500) 4.04
--------
Outstanding at December 31, 1997 37,250 4.22
Granted 32,527 9.67
Exercised (17,250) 4.04
Expired (1,500) 4.04
--------
Outstanding at December 31, 1998 51,027 7.70
--------
--------
</TABLE>
The following tables summarize information about stock options
outstanding at December 31, 1998:
<TABLE>
<CAPTION>
OPTIONS OUTSTANDING OPTIONS EXERCISABLE
------------------------------ ------------------------------
NUMBER AVERAGE WEIGHTED- NUMBER WEIGHTED-
RANGE OF OUTSTANDING AT REMAINING AVERAGE EXERCISABLE AT AVERAGE
EXERCISE DECEMBER 31, CONTRACTUAL EXERCISE DECEMBER 31, EXERCISE
PRICE 1998 LIFE PRICE 1998 PRICE
<S> <C> <C> <C> <C> <C>
$4.04 - $4.45 14,750 6.32 $ 4.06 13,000 $ 4.06
5.67 3,750 8.13 5.67 1,250 5.67
8.63 - 10.13 32,527 9.54 9.67
----------- -------------
51,027 8.50 7.70 14,250 4.20
----------- -------------
----------- -------------
</TABLE>
Stock option activity during the three months ended March 31, 1999 was
not significant.
-30-
<PAGE>
PART III
ITEM 1. INDEX TO EXHIBITS
<TABLE>
<CAPTION>
Exhibit No. Exhibit Description
- ----------- -------------------
<S> <C>
3.1 Restated Articles of Incorporation of the Company, as amended.
3.2 By-Laws of the Company, as amended.
4 Specimen of Common Stock certificate.
10.1 The Chromaline Corporation 1995 Stock Incentive Plan, as
amended.
10.2 Separation Agreement effective as of July 13,1998 between Thomas
L. Erickson and the Company.
10.3 Consulting Agreement dated July 22, 1998 between Thomas L.
Erickson and the Company.
10.4 Agreement regarding Non-Disclosure of Confidential Information
and Non-Competition dated July 22, 1998 between Thomas L.
Erickson and the Company.
10.5 Revolving Credit Agreement dated April 30, 1999 between the
Company and M&I Bank.
27 Financial Data Schedule.
</TABLE>
ITEM 2. DESCRIPTION OF EXHIBITS
Not applicable.
-31-
<PAGE>
SIGNATURES
In accordance with Section 12 of the Securities Exchange Act of 1934,
the Registrant has duly caused this Post-Effective Amendment No. 1 to
Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized.
THE CHROMALINE CORPORATION
Dated: July 8, 1999 By /s/ Philip J. Hourican
-----------------------------------------
Philip J. Hourican
President and Chief Executive Officer
By /s/ Jeffery A. Laabs
-----------------------------------------
Jeffery A. Laabs
Vice President of Finance,
Controller, Treasurer and Secretary
-32-
<PAGE>
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
Method
Exhibit Description of Filing
------- ----------- ---------
<S> <C> <C>
3.1 Restated Articles of Incorporation of the Company, as amended................ Previously Filed
3.2 By-Laws of the Company, as amended........................................... Previously Filed
4 Specimen of Common Stock certificate......................................... Previously Filed
10.1 The Chromaline Corporation 1995 Stock Incentive Plan, as amended............. Previously Filed
10.2 Separation Agreement effective as of July 13,1998 between Thomas L. Erickson
and the Company.............................................................. Previously Filed
10.3 Consulting Agreement dated July 22, 1998 between Thomas L. Erickson and the
Company...................................................................... Previously Filed
10.4 Agreement regarding Non-Disclosure of Confidential Information
and Non-Competition dated July 22, 1998 between Thomas L. Erickson
and the Company.............................................................. Previously Filed
10.5 Revolving Credit Agreement dated April 30, 1999 between the Company and M&I
Bank......................................................................... Previously Filed
27 Financial Data Schedule...................................................... Previously Filed
</TABLE>
-33-